603 Phase II Trial of Plinabulin in Combination with Nivolumab and Ipilimumab in Patients with Recurrent Small Cell Lung Cancer (SCLC): Big Ten Cancer Research Consortium (BTCRC-LUN17–127) Study
Journal for ImmunoTherapy of Cancer（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要